Fox Run Management, L.L.C. Catalent, Inc. Transaction History

Fox Run Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$100.34 - $115.69 $291,889 - $336,542	-2,909 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $295,292 - $364,410	2,909 New	2,909 $306,000
Q3 2020 Oct 29, 2020	SELL	$72.74 - $92.5 $409,598 - $520,867	-5,631 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$48.02 - $79.04 $270,400 - $445,074	5,631 New	5,631 $413,000
Q2 2019 Jul 17, 2019	SELL	$39.26 - $54.21 $495,343 - $683,967	-12,617 Closed	0 $0
Q1 2019 Oct 17, 2019	BUY	$29.84 - $43.92 $376,491 - $554,138	12,617 New	12,617 $512,000
Q4 2017 Jan 18, 2018	SELL	$37.27 - $43.02 $357,792 - $412,992	-9,600 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$33.75 - $41.67 $324,000 - $400,032	9,600	9,600 $383,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.